Analysis of Mechanism of Qinggan Jianpi Huoxue Prescription in Treatment of Hepatic Fibrosis Rats by Regulating M1/M2 Macrophages

PAN Fuzhen; CAO Hongxin; ZHANG Yongsheng; WU Xiaqiu; ZHENG Weifang; LIU Ding

doi:10.13422/j.cnki.syfjx.20231069

您当前的位置：

首页 >

文章列表页 >

Analysis of Mechanism of Qinggan Jianpi Huoxue Prescription in Treatment of Hepatic Fibrosis Rats by Regulating M1/M2 Macrophages

更新时间：2023-10-13

- Analysis of Mechanism of Qinggan Jianpi Huoxue Prescription in Treatment of Hepatic Fibrosis Rats by Regulating M1/M2 Macrophages
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 21, Pages: 94-102(2023)
- 作者机构：
  
  1.浙江中医药大学公共卫生学院，基础医学院，杭州 310053
  2.兰溪市中医院，浙江金华 321100
  3.中华中医药学会，北京 100029
  4.黑龙江中医药大学，哈尔滨 150040
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20231069
  CLC： R22;R28;R575;R96
- Published：05 November 2023，
  
  Published Online：31 May 2023，
  
  Received：07 February 2023，
- 稿件说明：
扫描看全文
潘富珍,曹洪欣,张永生等.清肝健脾活血方通过调控M1/M2型巨噬细胞治疗肝纤维化大鼠的作用机制分析[J].中国实验方剂学杂志,2023,29(21):94-102.

PAN Fuzhen,CAO Hongxin,ZHANG Yongsheng,et al.Analysis of Mechanism of Qinggan Jianpi Huoxue Prescription in Treatment of Hepatic Fibrosis Rats by Regulating M1/M2 Macrophages[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(21):94-102.
潘富珍,曹洪欣,张永生等.清肝健脾活血方通过调控M1/M2型巨噬细胞治疗肝纤维化大鼠的作用机制分析[J].中国实验方剂学杂志,2023,29(21):94-102. DOI： 10.13422/j.cnki.syfjx.20231069.

PAN Fuzhen,CAO Hongxin,ZHANG Yongsheng,et al.Analysis of Mechanism of Qinggan Jianpi Huoxue Prescription in Treatment of Hepatic Fibrosis Rats by Regulating M1/M2 Macrophages[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(21):94-102. DOI： 10.13422/j.cnki.syfjx.20231069.

摘要

目的

基于四氯化碳（CCl

）大鼠肝纤维化模型，探究清肝健脾活血方对肝纤维化大鼠M1/M2型巨噬细胞极化的影响。

方法

按剂量2.0 mL·kg

-1

给大鼠腹腔注射40% CCl

-橄榄油混悬液，每周2次，连续注射8周，建立大鼠肝纤维化模型，造模成功后随机分为模型组、清肝健脾活血方组（32.084 g·kg

-1

）、鳖甲煎丸组（0.925 5 g·kg

-1

），每组12只。空白组腹腔注射等量橄榄油。给药组按剂量灌胃给予相应药液，空白组和模型组给予相同剂量纯净水，1次/d，连续给药4周后取大鼠肝组织进行苏木素-伊红（HE）、马松（Masson）染色观察病理改变，并检测各组血清丙氨酸氨基转移酶（ALT）、天冬氨酸氨基转移酶（AST）水平，采用酶联免疫吸附测定法（ELISA）测定肝组织白细胞介素（IL）-6、IL-12、IL-10、IL-1

、转化生长因子-

（TGF-

）和肿瘤坏死因子-

（TNF-

）水平，免疫组化法（IHC）检测巨噬细胞CD86、CD206蛋白表达，蛋白免疫印迹法（Western blot）、实时荧光定量聚合酶链式反应（Real-time PCR）检测肝组织诱导型一氧化氮合酶（iNOS）、精氨酸酶1（Arg-1）、磷酸化p38丝裂原活化蛋白激酶（p-p38 MAPK）、核转录因子-

B p65（NF-

B p65）蛋白及mRNA表达水平。

结果

与空白组比较，模型组肝细胞板排列不规整，局部可见炎症细胞浸润、纤维增生，血清ALT、AST水平显著升高（

0.01），肝组织炎症因子IL-1

、IL-6、IL-12、TGF-

、TNF-

水平，CD86、CD206蛋白表达水平，iNOS、NF-

B p65蛋白及mRNA，p-p38 MAPK蛋白、p38 MAPK mRNA水平均明显升高（

0.05，

0.01），炎症因子IL-10，Arg-1蛋白及mRNA水平明显降低（

0.05，

0.01）；与模型组比较，清肝健脾活血方组肝细胞纤维化程度减轻，血清ALT、AST水平显著降低（

0.01）、肝组织炎症因子IL-1

、IL-6、IL-12、TGF-

、TNF-

水平，CD86表达水平，iNOS、NF-

B p65蛋白及mRNA水平，p-p38 MAPK蛋白及p38 MAPK mRNA水平明显降低（

0.05，

0.01），炎症因子IL-10，CD206表达水平、Arg-1蛋白及mRNA水平明显升高（

0.05，

0.01）。

结论

清肝健脾活血方可能通过抑制促炎M1型巨噬细胞激活，诱导M2型巨噬细胞分泌抗炎细胞因子，减少促纤维化细胞因子释放，促进肝巨噬细胞M1向有利于组织修复的M2型极化，从而发挥抗炎和抗肝纤维化作用。

Abstract

Objective

To observe the effect of Qinggan Jianpi Huoxue prescription（QGJPHXP） on the polarization of M1/M2 macrophages in rats with hepatic fibrosis induced by carbon tetrachloride（CCl

）.

Method

A rat hepatic fibrosis model was established by intraperitoneal injection of 40% CCl

-olive oil suspension twice a week at the dosage of 2.0 mL·kg

-1

for 8 weeks. After the model was successfully established， these rats were randomly divided into the model group， QGJPHXP group（32.084 g·kg

-1

） and Biejiajian pills（BJJP） group（0.925 5 g·kg

-1

）， with 12 rats in each group. The blank group was injected intraperitoneally with the same amount of olive oil. The rats in the administration groups were given the corresponding solution according to the dose， and the blank and model groups were given the same dose of purified water， once a day. After 4 weeks of continuous administration， the liver tissues of rats were taken and stained with hematoxylin-eosin（HE） and Masson to observe the pathological changes. The serums were collected to detect the alanine aminotransferase（ALT） and aspartate aminotransferase（AST） levels. Interleukin（IL）-6， IL-12， IL-10， IL-1

， transforming growth factor-

（TGF-

） and tumor necrosis factor-

（TNF-

） levels in liver tissues were measured by enzyme-linked immunosorbent assay（ELISA）. The expression levels of CD86 and CD206 were detected by immunohistochemistry（IHC）. Western blot and real-time fluorescence quantitative polymerase chain reaction（Real-time PCR） were used to detect the protein and mRNA expression levels of inducible nitric oxide synthase（iNOS）， arginase-1（Arg-1）， phosphorylated p38 mitogen-activated protein kinase（p-p38 MAPK）， nuclear transcription factor-

B p65（NF-

B p65） in liver tissues of rats.

Result

Compared with the blank group， the hepatic cell plate was irregularly arranged

and local inflammatory cell infiltration and fibrous hyperplasia were observed， while the serum levels of ALT and AST were significantly increased in the model group（

0.01）， and IL-1

， IL-6， IL-12， TGF-

， TNF-

， CD86， CD206， iNOS， p-p38 MAPK，p38 MAPK and NF-

B p65 levels in liver tissues were obviously increased（

0.05，

0.01）， while the levels of IL-10 and Arg-1 were obviously decreased（

0.05，

0.01）. Compared with the model group， QGJPHXP group reduced the degree of liver cell fibrosis，and serum levels of ALT and AST（

0.01）， and IL-1

， IL-6， IL-12， TGF-

， TNF-

， CD86， iNOS， p-p38 MAPK， p38 MAPK， and NF-

B p65 levels in liver tissues were obviously decreased（

0.05，

0.01）， the levels of IL-10， CD206 and Arg-1 were obviously increased in the QGJPHXP group（

0.05，

0.01）.

Conclusion

QGJPHXP has ability to inhibit the activation of pro-inflammatory M1 macrophages， induce the secretion of anti-inflammatory cytokines by M2 macrophages， reduce the release of pro-fibrogenic cytokines， and promote the macrophage polarization of M1 to M2 in liver for tissue repair， thereby serving as an anti-inflammatory and anti-hepatic fibrosis drug.

关键词

清肝健脾活血方免疫调控巨噬细胞极化肝纤维化炎症因子鳖甲煎丸病理变化

Keywords

Qinggan Jianpi Huoxue prescriptionimmune regulationmacrophage polarizationhepatic fibrosisinflammation factorsBiejiajian pillspathological changes

references

陆伦根，尤红，谢渭芬，等.肝纤维化诊断及治疗共识（2019年）［J］.肝脏，2019，24（9）：975-983，996.

CAMPANA L，ESSER H，HUCH M，et al.Liver regeneration and inflammation：From fundamental science to clinical applications［J］.Nat Rev Mol Cell Biol，2021，22（9）：608-624.

GINHOUX F，SCHULTZE J L，MURRAY P J，et al.New insights into the multidimensional concept of macrophage ontogeny，activation and function［J］.Nat Immunol，2016，17（1）：34-40.

WYNN T A，VANNELLA K M.Macrophages in tissue repair，regeneration，and fibrosis［J］.Immunity，2016，44（3）：450-462.

MURRAY P J，WYNN T A.Protective and pathogenic functions of macrophage subsets［J］.Nat Rev Immunol，2011，11（11）：723-737.

刘洋，何春雨，李彤等.鳖甲煎丸通过HIF-1α/NF-κB信号通路调控巨噬细胞极化的机制探讨［J］.中国实验方剂学杂志，2022，28（19）：9-16.

LIU P，LI H，GONG J，et al.Chitooligosaccharides alleviate hepatic fibrosis by regulating the polarization of M1 and M2 macrophages［J］.Food Funct，2022，13（2）：753-768.

HUANG G，LUO J，GUO H，et al.Molybdenum and cadmium co-exposure promotes M1 macrophage polarization through oxidative stress-mediated inflammatory response and induces pulmonary fibrosis in Shaoxing ducks （Anas platyrhyncha）［J］.Environ Toxicol，2022，37（12）：2844-2854.

赵益，徐国良，刘红宁，等.中药复方调节巨噬细胞极化的研究进展［J］.中华中医药杂志，2022，37（1）：297-301.

刘定，曹洪欣，潘富珍.从“五脏相关”理论探讨肝纤维化病机变化特点［J］.中华中医药杂志，2021，36（8）：4512-4514.

曹洪欣，赵凯维，王乐.中医治疗肿瘤标记物异常探讨［J］.中医杂志，2012，53（17）：1457-1459.

赵凯维，王乐，刘寨华，等.曹洪欣治疗肿瘤标记物异常临床经验［J］.中国中医基础医学杂志，2016，22（4）：497-498，544.

李金霞，许继文，曹洪欣.鼓胀的分期辨治［J］.中医杂志，2017，58（16）：1421-1422.

潘富珍，刘定，杨沈秋，等.清肝健脾活血方对四氯化碳诱导肝纤维化大鼠氧化应激的影响［J］.江苏中医药，2022，54（4）：66-71.

郑君，林晓春，胡建兰，等.四氯化碳致大鼠肝纤维化模型的建立［J］.安徽医学，2014，35（5）：553-555.

黄继汉，黄晓晖，陈志扬，等.药理试验中动物间和动物与人体间的等效剂量换算［J］.中国临床药理学与治疗学，2004，9（9）：1069-1072.

SCHUPPAN D，KIM Y O.Evolving therapies for liver fibrosis［J］.J Clin Invest，2013，123（5）：1887-1901.

BEATTIE L，SAWTELL A，MANN J，et al.Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions［J］.J Hepatol，2016，65（4）：758-768.

TACKE F，ZIMMERMANN H W.Macrophage heterogeneity in liver injury and fibrosis［J］.J Hepatol，2014，60（5）：1090-1096.

MILLS E L，KELLY B，LOGAN A，et al.Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages［J］.Cell，2016，167（2）：457-470.

MURRAY P J，WYNN T A.Protective and pathogenic functions of macrophage subsets［J］.Nat Rev Immunol，2011，11（11）：723-737.

SHAPOURI-MOGHADDAM A，MOHAMMADIAN S，VAZINI H，et al.Macrophage plasticity，polarization，and function in health and disease［J］.J Cell Physiol，2018，233（9）：6425-6440.

SICA A，MANTOVANI A.Macrophage plasticity and polarization：in vivo veritas［J］.J Clin Invest，2012，122（3）：787-795.

OHASHI W，HATTORI K，HATTORI Y.Control of macrophage dynamics as a potential therapeutic approach for clinical disorders involving chronic inflammation［J］.J Pharmacol Exp Ther，2015，354（3）：240-250.

TIAN L，LI W，YANG L，et al.Cannabinoid receptor 1 participates in liver inflammation by promoting M1 macrophage polarization via RhoA/NF-kappaB p65 and ERK1/2 pathways，respectively，in mouse liver fibrogenesis［J］.Front Immunol，2017，8：12-14.

WYNN T A.Fibrotic disease and the TH1/TH2 paradigm［J］.Nat Rev Immunol，2004，4（8）：583-594.

PESCE J T，RAMALINGAM T R，MENTINK-KANE M M，et al.Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis［J］.PLoS Pathog，2009，5（4）：e1000371.

TSUCHIDA T，FRIEDMAN S L.Mechanisms of hepatic stellate cell activation［J］.Nat Rev Gastroenterol Hepatol，2017，14（7）：397-411.

李子舜，赵长普，陈仁伍，等.中医药基于NF-κB信号通路治疗肝纤维化的研究进展［J］.中国实验方剂学杂志，2023，doi：10.13422/j.cnki.syfjx.20231244http://dx.doi.org/10.13422/j.cnki.syfjx.20231244.

HAN J，WANG J，WANG Y，et al.Sesquiterpene lactones-enriched fractions from Xanthium mongolicum Kitag alleviate RA by regulating M1 macrophage polarization via NF-κB and MAPK signaling pathway［J］.Front Pharmacol，2023，14：1104153.

ZHAO D，XUE C，YANG Y，et al.Lack of Nogo-B expression ameliorates PPARγ deficiency-aggravated liver fibrosis by regulating TLR4-NF-κB-TNF-α axis and macrophage polarization［J］.Biomed Pharmacother，2022，153：113444.

CHONG S，CHEN G，DANG Z，et al.Echinococcus multilocularis drives the polarization of macrophages by regulating the RhoA-MAPK signaling pathway and thus affects liver fibrosis［J］.Bioengineered，2022，13（4）：8747-8758.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism of Huangwu Ganfu Ointment in Treatment of Peripheral Inflammatory Hyperalgesia of Knee Osteoarthritis Based on TRPV1

Effect of Xuefu Zhuyu Capsules on Polarization of Macrophages in Mice with Atherosclerosis

Pathogenesis of Idiopathic Pulmonary Fibrosis and Modulating Effect of Chinese Medicine： A Review

Role of Macrophage Polarization in Chronic Low-grade Inflammation of PCOS Based on Theory of Spleen Being in Charge of Defensive Function

Efficacy of Tiaogan Huaxian Pills in Prevention and Treatment of Hepatic Fibrosis in Hepatitis B and Its Effect on Diffusion-weighted Imaging

Related Author

JIANG Chuyang

WANG Zhaonan

JIANG Hongliang

ZHAO Ziwei

ZHAO Le

MA Yanmiao

LI Yanyan

LIU Menghua

Related Institution

Affiliated Hospital of Shanxi University of TCM

Shanxi University of Traditional Chinese Medicine（TCM）

Dongzhimen Hospital，Beijing University of Chinese Medicine

The Affiliated Hospital of Jiangxi University of Chinese Medicine

National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine， Jiangxi University of Chinese Medicine

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰